Clin2
NCT07594301Likely a fitRecruiting

Minocycline after successful stroke clot removal in the back brain

Acute Ischemic StrokeEndovascular ThrombectomyMinocyclinePosterior CirculationArterial Occlusion

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests whether an antibiotic called minocycline can reduce brain damage after doctors successfully remove a blood clot from the back of the brain (posterior circulation stroke) using a catheter procedure. The drug may help protect brain tissue and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
234 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • 18 years or older
  • Stroke symptoms started within the last 24 hours (or upon waking up)
  • Moderate to severe stroke symptoms (NIHSS score of 6 or higher)
  • Brain imaging shows good tissue remaining in the back of the brain (ASPECTS score of 6 or higher)
  • Blood clot successfully removed from the vertebral or basilar artery in the back of the brain
  • Able to give written consent or have a legal representative do so

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07594314Recruiting· Phase 2/Phase 3
Minocycline after stroke clot removal surgery

This trial tests whether minocycline, an antibiotic, can reduce brain damage when given after successful clot removal surgery for acute stroke. The goal is to see if this medication helps patients recover better.

Wuhan, Hubei
NCT07672795Recruiting
Clot removal treatment for severe stroke in the back of the brain

This study tests whether a minimally invasive procedure to remove a large blood clot from the main artery at the back of the brain can help people who have had a severe stroke. It aims to improve recovery and reduce disability.

Hefei, Anhui
NCT07115940Recruiting
Clot removal after 24 hours for stroke patients

This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.

Chicago, Illinois
NCT07617870Not yet recruiting· Phase 3
Clot-busting treatment for late-window posterior stroke

This study tests whether a clot-busting drug called pro-urokinase can help people with a stroke in the back of the brain when given later than usual (4.5 to 9 hours after symptoms start). The goal is to see if it improves recovery and reduces disability.

Zhengzhou, Henan
NCT07699029Recruiting
Clot removal for stroke in the back of the brain after 24 hours

This study tests a procedure to remove blood clots from large arteries in the back of the brain up to 14 days after a stroke starts. It may help people who have had a stroke more than a day ago and still have significant disability.

Wuhan, Hubei
NCT07526987Recruiting· Phase 3
Minocycline to Help Recovery After Acute Stroke Treatment

This study tests whether an antibiotic called minocycline, given alongside standard stroke treatment (clot-busting medication), can help reduce brain damage and improve recovery. You would receive minocycline around the time of your clot-busting treatment.

Liaocheng, Shandong

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.